Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00981032 · ClinicalTrials.gov registry record · NA
Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 884
- Enrollment target
NCT00981032 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 884 participants.
The verdict
NCT00981032, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 884 participants
- Enrollment target
Study Summary
The investigators' aim is to implement an intervention to increase aspirin prophylaxis use among patients that is patient initiated, optimizes use of physician and staff time, appropriately compensates staff, provides clinicians with tools necessary for managing aspiring prophylaxis, and ensures continuous management.
Interventions
- BEHAVIORAL Pre-visit Summary
- BEHAVIORAL Clinical Decision Sharing Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 884 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00981032
The ClinicalTrials.gov registry entry for NCT00981032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 884 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pre-visit Summary is the first listed.
NCT00981032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00981032 about?
NCT00981032 is a clinical study titled "Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)". The investigators' aim is to implement an intervention to increase aspirin prophylaxis use among patients that is patient initiated, optimizes use of physician and staff time, appropriately compensates staff, provides clinicians with tools necessary for managing aspiring prophylaxis, and ensures con...
What is the current status of trial NCT00981032?
This trial is currently completed. It is a NA study. The enrollment target is 884 participants. The study started on 2009-10. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00981032?
The interventions under investigation include: Pre-visit Summary (BEHAVIORAL), Clinical Decision Sharing Tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT00981032?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.